ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Pediatric Solid Organ Transplant Recipients; Single Center Experience

S. Alharbi1, A. Aljedai2, D. Alkortas2

1Pharmaceutical Care Division, KFSH&RC, riyadh, Saudi Arabia, 2Pharmaceutical Care Division, KFSH&RC, Riyadh, Saudi Arabia

Meeting: 2021 American Transplant Congress

Abstract number: 721

Keywords: Cytomeglovirus, Dosage, Ganciclovir, Pediatric

Topic: Clinical Science » Infectious Disease » All Infections (Excluding Kidney & Viral Hepatitis)

Session Information

Session Name: All Infections (Excluding Kidney & Viral Hepatitis)

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: The main objective of the study is to compare the efficacy of the different Valganciclovir dosing strategies in pediatric solid organ transplant recipients with safety evaluated as a secondary endpoint.

*Methods: This is a retrospective cohort study of all pediatric patients who underwent kidney or liver transplantation at King Faisal Specialist Hospital and Research Centre and received VGC as CMV prophylaxis between 2010 and 2018. Subjects aged 14 years or less were included. The primary goal is to compare the incidence of CMV infection between the three dosing regimens.

*Results: One hundred and fifty patients were included; 50 patients in each dosing group. Patient’s characteristics were similar amongst the groups except for the CMV donor/recipient status, who were present in 8 out of the 50 patients in the equation-based regimen (16%) versus none in the other two groups. Overall, CMV infection was significantly higher in patients who received BSA-based regimen 26 out of 50 (52%) vs. equation-based regimen 22 out of 50 (44%) vs. weight-based regimen 12 out of 50 (24%). Of those, CMV disease occurred in 14 of 26 (53.85%) in BSA-based regimen vs 6 out of 22 (27.27%) in equation-based regimen vs 6 out of 12 (50%) in weight-based regimen

*Conclusions: Weight-based regimen was more effective in preventing CMV infection. However, prophylaxis duration differed greatly between the groups, as well as the higher number of mismatched recipients in the equation-based group; both of these factors could have contributed to the findings. Further analysis is needed to confirm the findings.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Alharbi S, Aljedai A, Alkortas D. Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Pediatric Solid Organ Transplant Recipients; Single Center Experience [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/valganciclovir-dosing-for-cytomegalovirus-prophylaxis-in-pediatric-solid-organ-transplant-recipients-single-center-experience/. Accessed June 1, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences